GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (OTCPK:BRSYF) » Definitions » Cyclically Adjusted PB Ratio

BrainsWay (BrainsWay) Cyclically Adjusted PB Ratio : 3.09 (As of May. 26, 2024)


View and export this data going back to 2012. Start your Free Trial

What is BrainsWay Cyclically Adjusted PB Ratio?

As of today (2024-05-26), BrainsWay's current share price is $2.47. BrainsWay's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.80. BrainsWay's Cyclically Adjusted PB Ratio for today is 3.09.

The historical rank and industry rank for BrainsWay's Cyclically Adjusted PB Ratio or its related term are showing as below:

BRSYF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.56   Med: 2.37   Max: 2.89
Current: 2.25

During the past years, BrainsWay's highest Cyclically Adjusted PB Ratio was 2.89. The lowest was 1.56. And the median was 2.37.

BRSYF's Cyclically Adjusted PB Ratio is ranked worse than
51.8% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs BRSYF: 2.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BrainsWay's adjusted book value per share data for the three months ended in Mar. 2024 was $1.262. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.80 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


BrainsWay Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BrainsWay's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Cyclically Adjusted PB Ratio Chart

BrainsWay Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.62

BrainsWay Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.77 2.62 2.32

Competitive Comparison of BrainsWay's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, BrainsWay's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrainsWay's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BrainsWay's Cyclically Adjusted PB Ratio falls into.



BrainsWay Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BrainsWay's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.47/0.8
=3.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrainsWay's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, BrainsWay's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.262/131.7762*131.7762
=1.262

Current CPI (Mar. 2024) = 131.7762.

BrainsWay Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 1.046 99.070 1.391
201503 1.025 99.621 1.356
201506 0.931 100.684 1.219
201509 0.919 100.392 1.206
201512 0.890 99.792 1.175
201603 0.864 100.470 1.133
201606 0.820 101.688 1.063
201609 0.776 101.861 1.004
201612 0.699 101.863 0.904
201703 0.580 102.862 0.743
201706 0.501 103.349 0.639
201709 0.408 104.136 0.516
201712 0.764 104.011 0.968
201803 0.717 105.290 0.897
201806 0.611 106.317 0.757
201809 0.532 106.507 0.658
201812 0.418 105.998 0.520
201903 0.250 107.251 0.307
201906 1.286 108.070 1.568
201909 1.181 108.329 1.437
201912 1.089 108.420 1.324
202003 0.948 108.902 1.147
202006 0.928 108.767 1.124
202009 0.886 109.815 1.063
202012 0.882 109.897 1.058
202103 1.864 111.754 2.198
202106 1.813 114.631 2.084
202109 1.771 115.734 2.016
202112 1.742 117.630 1.952
202203 1.690 121.301 1.836
202206 1.626 125.017 1.714
202209 1.480 125.227 1.557
202212 1.373 125.222 1.445
202303 1.297 127.348 1.342
202306 1.247 128.729 1.277
202309 1.242 129.860 1.260
202312 1.251 129.419 1.274
202403 1.262 131.776 1.262

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BrainsWay  (OTCPK:BRSYF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BrainsWay Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BrainsWay's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BrainsWay (BrainsWay) Business Description

Traded in Other Exchanges
Address
19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.